SYRE
Spyre Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -7.1% ·
Aktienfluss -1.7% ·
neue Nettopositionen -7.7%
— Formel
Breite Distribution — sinkende Anteile und weniger Halter
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 99 | +22 | 55.43M | $4.93B | +25 | −3 |
| Q1 2026 | 80 | +10 | 41.69M | $2.10B | +12 | −2 |
| Q4 2025 | 69 | +2 | 41.90M | $1.37B | +2 | — |
| Q3 2025 | 13 | -1 | 23.21M | $388.94M | +1 | −2 |
| Q2 2025 | 11 | 0 | 22.40M | $335.38M | +2 | −2 |
| Q1 2025 | 8 | -2 | 6.01M | $96.96M | — | −2 |
| Q4 2024 | 10 | +1 | 7.67M | $178.64M | +2 | −1 |
| Q3 2024 | 8 | 0 | 4.78M | $140.58M | +1 | −1 |
| Q2 2024 | 8 | — | 3.96M | $93.00M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 9.06M | +0.1% | $151.85M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 9.06M | +0.1% | $151.85M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 9.06M | +0.1% | $151.85M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (passiv) | 3.98M | -0.6% | $66.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passiv) | 3.98M | -0.6% | $66.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passiv) | 3.98M | -0.6% | $66.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passiv) | 3.98M | -0.6% | $66.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passiv) | 3.98M | -0.6% | $66.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passiv) | 3.98M | -0.6% | $66.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passiv) | 3.98M | -0.6% | $66.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passiv) | 3.98M | -0.6% | $66.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | BlackRock ✦ (passiv) | 3.98M | -0.6% | $66.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | BlackRock ✦ (passiv) | 3.98M | -0.6% | $66.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | BlackRock ✦ (passiv) | 3.98M | -0.6% | $66.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passiv) | 3.05M | -0.5% | $51.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passiv) | 3.05M | -0.5% | $51.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | The Vanguard Group ✦ (passiv) | 3.05M | -0.5% | $51.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passiv) | 3.05M | -0.5% | $51.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | The Vanguard Group ✦ (passiv) | 3.05M | -0.5% | $51.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | State Street Global Advisors ✦ (passiv) | 1.79M | +11.9% | $29.92M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | Wellington Management ✦ | 1.64M | +8.4% | $27.49M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 22 | Wellington Management ✦ | 1.64M | +8.4% | $27.49M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 23 | Wellington Management ✦ | 1.64M | +8.4% | $27.49M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 24 | Wellington Management ✦ | 1.64M | +8.4% | $27.49M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 25 | Wellington Management ✦ | 1.64M | +8.4% | $27.49M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 26 | Geode Capital Management ✦ (passiv) | 1.23M | -0.2% | $20.54M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 27 | Geode Capital Management ✦ (passiv) | 1.23M | -0.2% | $20.54M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 28 | T. Rowe Price ✦ | 620.62K | -33.3% | $10.40M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 29 | T. Rowe Price ✦ | 620.62K | -33.3% | $10.40M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 30 | JPMorgan Chase ✦ | 551.97K | — | $9.25M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 551.97K | — | $9.25M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 551.97K | — | $9.25M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 551.97K | — | $9.25M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 551.97K | — | $9.25M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 551.97K | — | $9.25M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 551.97K | — | $9.25M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 551.97K | — | $9.25M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | Millennium Management ✦ | 408.20K | Neu | $6.84M | 0.0% | New | 1 | SEC ↗ |
| 39 | Morgan Stanley ✦ | 334.72K | — | $5.61M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Morgan Stanley ✦ | 334.72K | — | $5.61M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Morgan Stanley ✦ | 334.72K | — | $5.61M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Morgan Stanley ✦ | 334.72K | — | $5.61M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Morgan Stanley ✦ | 334.72K | — | $5.61M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | Morgan Stanley ✦ | 334.72K | — | $5.61M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | Goldman Sachs Group ✦ | 329.53K | — | $5.52M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Goldman Sachs Group ✦ | 329.53K | — | $5.52M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | Capital World Investors ✦ | 200.17K | -42.9% | $3.35M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 48 | AQR Capital Management ✦ | 17.05K | -5.2% | $285,709 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 49 | AQR Capital Management ✦ | 17.05K | -5.2% | $285,709 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 50 | AQR Capital Management ✦ | 17.05K | -5.2% | $285,709 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 51 | AQR Capital Management ✦ | 17.05K | -5.2% | $285,709 | 0.0% | ▼ Trim | 2 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Millennium Management | $6.84M | 0.0% |
Ausgestiegen
| Adage Capital Partners | $9.13M | war 0.0% |
| Renaissance Technologies | $463,112 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 197 Inhaber, 82.12M Anteile, $4.06B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Käufe auf dem offenen Markt (P)
Keine Insider-Käufe auf dem offenen Markt in unserem Erfassungszeitraum.
Verkäufe auf dem offenen Markt (S)
Director · 5.00K Ant. · $522,350
Director · 8.00K Ant. · $835,040
Director · 10.00K Ant. · $1.05M
Zuteilungen, Ausübungen und Steuereinbehalte werden hier nie als Käufe oder Verkäufe gezählt. Methodik
9.2% der Klasse · Original-SEC-Einreichung anzeigen ↗